Rare diseases
Investigational molecules
Locations
Isokatu 8 B 8, 90100 Oulu, Finland
Oulu Mentalcare Oy in Oulu, Finland specialises in clinical trials of conditions such as Major depression, Generalised anxiety disorder, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Generalized Anxiety Disorder (GAD), focusing on innovative therapeutic approaches to improve patient outcomes. The center's research is dedicated to evaluating the efficacy of novel treatments, such as SEP-363856, in managing anxiety symptoms.
Through rigorous clinical trials, the center aims to enhance the understanding of GAD and develop effective interventions that can be integrated into clinical practice, ultimately improving the quality of life for individuals affected by this condition.
Specializing in Major Depressive Disorder (MDD), the medical center is committed to advancing the treatment landscape through comprehensive research initiatives. The focus is on assessing the long-term safety and effectiveness of promising compounds like NMRA-335140, which target specific neural pathways involved in depression.
By conducting extensive studies, the center contributes to the development of new therapeutic options that offer hope for sustained remission and improved mental health for those living with MDD.
Clinical trials currently enrolling participants at this site.
Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments
FinlandSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
FinlandEvaluating NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder Who Are Not Responding Adequately to Current Therapy
FinlandStudy on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment
FinlandLong‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
FinlandA study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder
FinlandFinlandFinlandStudy on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder
FinlandStudy on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants
FinlandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
